Journal of Medical Virology · 2000 · 88 citations · 19 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular VirologyVaccinologyVirologyVaccinationViral VaccinesDna Sequence AnalysisDna Sequence Data AnalysisImmediate-early Viral GenesPromotersVaricella InfectionVaricella VaccinationVaricella-zoster VaccinesVaricella-zoster Virus Infections
When the nucleotide sequences of the Oka vaccine and its parental varicella-zoster virus (VZV) were compared in 6 open reading frames (ORFs), glycoprotein C (gC) and 5 transactivator genes, mutations were detected only in the immediate-early gene 62. The vaccine virus contained a mixture of different sequences that had variations at 15 nucleotide positions, but only one sequence was found for the Oka parental virus gene 62. The Oka vaccine virus gene 62 could be distinguished from the parental virus gene using a simplified restriction-enzyme fragment length polymorphism analysis, using NaeI and BssHII. This analysis was based on the sequence data obtained in this study. Studies of the regulatory activities of the ORF62 gene product (IE62) in a transient transfection assay indicated that IE62 of the parental virus had a stronger transactivational activity than that of the vaccine virus in activating immediate-early, early, and late gene promoters. These data suggest that IE62 might play an important role in the attenuation of VZV.
19
The Complete DNA Sequence of Varicella-Zoster Virus
Andrew J. Davison, J. E. Scott · Journal of General Virology · 1986 · 1.4K citations
LIVE VACCINE USED TO PREVENT THE SPREAD OF VARICELLA IN CHILDREN IN HOSPITAL
Michiaki Takahashi, Terumasa Otsuka, Yoshiomi Okuno et al. · The Lancet · 1974 · 737 citations
Jennifer F. Moffat, Leigh Zerboni, Paul R. Kinchington et al. · Journal of Virology · 1998 · 225 citations · Full text
Philip LaRussa, Octavian Lungu, Iain R. B. Hardy et al. · Journal of Virology · 1992 · 208 citations · Full text